- Home
- FRPH vs AXGN Comparison
FRPH vs AXGN Comparison
Compare FRPH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- AXGN
- Stock Information
- Founded
- FRPH 1986
- AXGN N/A
- Country
- FRPH United States
- AXGN United States
- Employees
- FRPH N/A
- AXGN N/A
- Industry
- FRPH Real Estate
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FRPH Finance
- AXGN Health Care
- Exchange
- FRPH Nasdaq
- AXGN Nasdaq
- Market Cap
- FRPH 525.9M
- AXGN 538.3M
- IPO Year
- FRPH N/A
- AXGN N/A
- Fundamental
- Price
- FRPH $27.12
- AXGN $10.89
- Analyst Decision
- FRPH
- AXGN Strong Buy
- Analyst Count
- FRPH 0
- AXGN 6
- Target Price
- FRPH N/A
- AXGN $23.83
- AVG Volume (30 Days)
- FRPH 50.4K
- AXGN 749.9K
- Earning Date
- FRPH 05-12-2025
- AXGN 05-08-2025
- Dividend Yield
- FRPH N/A
- AXGN N/A
- EPS Growth
- FRPH 12.32
- AXGN N/A
- EPS
- FRPH 0.36
- AXGN N/A
- Revenue
- FRPH $31,576,000.00
- AXGN $194,520,000.00
- Revenue This Year
- FRPH N/A
- AXGN $18.02
- Revenue Next Year
- FRPH N/A
- AXGN $16.25
- P/E Ratio
- FRPH $75.46
- AXGN N/A
- Revenue Growth
- FRPH 4.58
- AXGN 18.81
- 52 Week Low
- FRPH $25.37
- AXGN $6.57
- 52 Week High
- FRPH $33.00
- AXGN $21.00
- Technical
- Relative Strength Index (RSI)
- FRPH 49.71
- AXGN 28.41
- Support Level
- FRPH $26.94
- AXGN $10.77
- Resistance Level
- FRPH $28.35
- AXGN $11.58
- Average True Range (ATR)
- FRPH 0.92
- AXGN 0.59
- MACD
- FRPH 0.07
- AXGN 0.02
- Stochastic Oscillator
- FRPH 49.38
- AXGN 18.67
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.